Knowledge Hub

Global Veterinary Vaccines Market to reach US$ 11.4 Bn in 2024

Press Release   •   Oct 17, 2016 07:53 EDT has recently announced the addition of a market study “ Veterinary Vaccines Market (Animal Type - Companion Animals (Equine, Canine, Feline), Livestock Animals (Bovine, Ovine, Porcine, Poultry); Technology Type - Inactivated Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Toxoid Vaccines) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 ”, is acomparative analysis of the global market.

Veterinary vaccines are extensively used in the prevention of life-threatening animal diseases. This report on the global veterinary vaccines market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, which includes a market snapshot providing overall information on various segments and sub-segments. This section also provides complete information and data analysis of the global veterinary vaccines market with respect to the leading market segments based on technology type, animal type, and geography.

The report is a combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via email. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various national and international databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro-environmental factors. Growth rates for each segment within the global veterinary vaccines market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, vaccination expenditure, and regulatory requirements.

Increase in prevalence of animal diseases, surge in investments by government bodies, rise in demand for milk, meat, eggs, and fish; high expenditure on companion animals, and growing awareness about vaccination among the middle class are the major factors that propel demand for veterinary vaccines. Stringent market regulations and high R&D cost are the major factors likely to hamper the veterinary vaccines market.

The market overview section of the report includes qualitative analysis of the overall veterinary vaccines market including the determining factors and market dynamics such as drivers, restraints, and opportunities, along with white space analysis. In addition, market attractiveness analysis by geography, animal type, and technology type, and competitive landscape by key players have been provided which explain the intensity of competition in the market considering different geographies. The competitive scenario between market players has been evaluated through market share analysis. These factors would help the market players take strategic decisions in order to strengthen their positions and increase their shares in the global market.

Download The sample Copy Of This Report:

The global veterinary vaccines market has been segmented based on technology type, animal type, and geography. Based on technology type, the market has been categorized into inactivated vaccines, live attenuated vaccines, conjugate vaccines, toxoid vaccines, and other vaccines such as recombinant vaccines, DNA vaccines, and subunit vaccines. Companion vaccines and livestock vaccines are the major segments by animal type. The companion vaccines segment comprises canine vaccines, feline vaccines, and equine vaccines. The livestock vaccines segment includes porcine, poultry, bovine, ovine, and other vaccines. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 has been provided for all the segments, considering 2015 as the base year.

Geographically, the veterinary vaccines market has been categorized into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The mentioned regions are further analyzed by major countries contributing to the market. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the veterinary vaccines market. The report also profiles major players based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players in the global veterinary vaccines market are Bayer AG, Bimeda, Inc., Boehringer Ingelheim GmbH, Ceva Santé Animale, Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi S.A. (Merial Animal Health), Virbac, and Zoetis, Inc.

The global veterinary vaccines market has been segmented as follows:

Global Veterinary Vaccines Market, by Animal Type

Animal Type

Companion Animals




Livestock Animals






Global Veterinary Vaccines Market, by Technology Type

Inactivated Vaccines

Live Attenuated Vaccines

Conjugate Vaccines

Toxoid Vaccines

Other Vaccines

Global Veterinary Vaccines Market, by Geography

North America






Asia Pacific



Rest of Asia Pacific

Latin America



Middle East & Africa

Saudi Arabia

Rest of MEA